Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
100%
Chagas Disease
72%
Parasite
71%
Visceral Leishmaniasis
64%
African Trypanosomiasis
62%
Mouse Model
61%
Pharmacokinetics
59%
Trypanosoma Brucei
49%
Trypanosoma Cruzi
48%
Diseases
47%
Antimalarial Agent
44%
Infection
42%
Structure Activity Relationship
41%
Tuberculosis
40%
Mycobacterium Tuberculosis
39%
Enzymes
33%
Plasmodium falciparum
32%
Rat
30%
Carboxamide
29%
Mode of Action
28%
Cytotoxicity
28%
Antimalarial Activity
27%
Trypanosomatidae
23%
Malaria
23%
Drug Development
23%
Lysine Transfer RNA Ligase
22%
Nifurtimox
21%
Cytochrome P450
20%
Receptor
20%
Drug-Drug Interaction
18%
Pharmaceutical Chemistry
18%
Cyclin Dependent Kinase
16%
Protozoan
16%
Trypanosoma
16%
Fexinidazole
16%
Lipophilicity
15%
Clinical Trial
14%
Plasmodium
14%
Pyrimidine Derivative
14%
Oxidoreductase
14%
Anticonvulsive Agent
14%
High-Throughput Screening
13%
Drug Metabolism
13%
Side Effect
13%
Hexachlorophene
13%
Proteasome
13%
EC50
12%
Pyrimidine
12%
Sulfonamide
12%
Urea
11%
Keyphrases
Drug Discovery
54%
Visceral Leishmaniasis
47%
Human African Trypanosomiasis
40%
Chagas Disease
40%
Trypanosoma Cruzi (T. cruzi)
40%
Mycobacterium Tuberculosis (M. tb)
30%
Trypanosoma Brucei
24%
Drug Target
24%
Trypanocidal Activity
23%
Anti-trypanosomatid Drugs
22%
N-myristoyltransferase Inhibitors
22%
Phenotypic Screening
20%
Wellcome
20%
New Drugs
18%
Antimalarial Activity
17%
Preclinical Candidate
17%
Plasmodium Falciparum
17%
Nifurtimox
17%
Drug Development
16%
Mouse Model
16%
Medicinal Chemistry
15%
In Vivo Efficacy
15%
Structure-activity Relationship
15%
Humanized Mouse Model
14%
Anti-infective
14%
Cytochrome P450 (CYP450)
14%
Lead Optimization
14%
Trypanosoma
14%
Central Nervous System
14%
Metabolism
13%
Antitubercular Agents
13%
Drug Interactions
13%
Benznidazole
12%
Protozoan Parasites
12%
Mode of Action
12%
Physicochemical Properties
12%
Malaria
12%
Sperm Motility
12%
Current Treatment
12%
N-myristoyltransferase
11%
LysR Family
11%
Brain Penetrant
11%
Public Engagement
11%
High-throughput Phenotypic Screening
11%
Triage
11%
Apologizing
11%
Infectious Diseases
11%
Cyclin-dependent Kinase 12
11%
Schistosomiasis
11%
2,4-diaminopyrimidine
11%